Globus Medical Inc. logo

Globus Medical Inc. (GMED)

Market Closed
17 Jul, 20:00
NYSE NYSE
$
77. 00
-3.91
-4.8325%
$
10.59B Market Cap
48.4 P/E Ratio
- Div Yield
2.27M Volume
2.69 Eps
$ 80.91
Previous Close
Add Transaction
Day Range
76.26 80.74
Year Range
51.79 101.4
Want to track GMED and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

GMED closed yesterday lower at $77, a decrease of -4.8325% from Thursday's close, completing a monthly decrease of -5.1607% or -$4.19. Over the past 12 months, GMED stock lost -11.606%.
GMED is not paying dividends to its shareholders.
The last earnings report, released on May 14, 2026, missed the consensus estimates by -0.88%. On average, the company has fell short of earnings expectations by -0.6467%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 7 different exchanges and in various currencies, with the primary listing on NYSE (USD).

GMED Chart

People also search for

ABT
Abbott Laboratories
$ 100.68
+1.8719%
PFE
Pfizer Inc.
$ 25.05
-0.358%
CVS
CVS Health Corporation
$ 107.47
+0.9108%
SYK
Stryker Corporation
$ 319.87
-3.4209%
MDT
Medtronic plc
$ 83.2
-0.4308%
GMED Stock Surges 43.6% in a Year: What's Driving the Rally?

GMED Stock Surges 43.6% in a Year: What's Driving the Rally?

Globus Medical's 43.6% one-year rally is fueled by strong growth across both business segments, rising technology adoption and a debt-free balance sheet.

Zacks | 1 day ago
Here's Why Globus Medical (GMED) is a Strong Value Stock

Here's Why Globus Medical (GMED) is a Strong Value Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks | 2 days ago
Here's Why Globus Medical (GMED) is a Strong Momentum Stock

Here's Why Globus Medical (GMED) is a Strong Momentum Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks | 2 weeks ago

Globus Medical Inc. Investors

Name Quantity Cost Value Profit ($) Gain (%)
CE
Curtis Ellergodt Rothschild Investment LLC
9,384 $505,149.64 $734,954.88 $229,805.24 45.49%
JJT
John J. Terril TERRIL BROTHERS Inc.
53,915 $2.68M $4.22M $1.54M 57.6%
ABB
Alexander Bjornager Bonde Danske Bank A/S
300 $26,193 $23,496 -$2,697 -10.3%
JD
Jim Dushek HARBOUR INVESTMENTS Inc.
133 $11,462.73 $10,397.27 -$1,065.46 -9.29%
Farallon Capital
Farallon Capital Farallon Capital Management LLC
4,000 $236,080 $312,920 $76,840 32.55%

Globus Medical Inc. (GMED) FAQ

What is the stock price today?

The current price is $77.00.

On which exchange is it traded?

Globus Medical Inc. is listed on NYSE.

What is its stock symbol?

The ticker symbol is GMED.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 10.59B.

Has Globus Medical Inc. ever had a stock split?

No, there has never been a stock split.

Globus Medical Inc. Profile

Health Care Equipment & Supplies Industry
Healthcare Sector
Keith W. Pfeil CEO
NYSE Exchange
379577208 CUSIP
US Country
6,000 Employees
- Last Dividend
- Last Split
3 Aug 2012 IPO Date

Overview

Globus Medical, Inc. is a prominent medical device company focused on innovating healthcare solutions for patients dealing with musculoskeletal disorders, serving both the United States and international markets. Since its inception in 2003, Globus Medical has been at the forefront of developing a wide range of medical devices aimed at improving the quality of life for patients suffering from a variety of conditions, including degenerative and congenital disorders, deformities, tumors, and trauma injuries. With its headquarters located in Audubon, Pennsylvania, Globus Medical has established a strong global presence, distributing its products through a mix of direct sales, distributor representatives, and independent sales agents.

Products and Services

Globus Medical, Inc. offers an extensive portfolio of products and solutions across multiple domains within the musculoskeletal treatment spectrum:

  • Spine Products: This category includes traditional fusion implants like pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices designed for treating a range of conditions from degenerative diseases to trauma injuries. Additionally, motion preservation technologies such as dynamic stabilization, total disc replacement, and interspinous distraction devices are available for patients seeking alternatives to traditional spine fusion procedures.
  • Interventional Solutions: Aimed at treating vertebral compression fractures, the company offers a variety of minimally invasive options that cater to this common yet painful consequence of osteoporosis and other conditions leading to weakened bones.
  • Regenerative Biologic Products: In pursuit of aiding the body's natural healing process, Globus Medical provides an assortment of regenerative products including both allografts (donated human tissue) and synthetic alternatives, enabling a broad range of applications from bone growth to tissue repair.
  • Orthopedic Trauma: For treating injuries related to trauma, the company offers a comprehensive suite of products including fracture plates, compression screws, intramedullary nails, and external fixation systems, facilitating the proper alignment and stabilization needed for effective healing.
  • Hip and Knee Joint Solutions: Focusing on joint replacement, Globus Medical provides modular hip stems and acetabular cups for hip surgeries, along with posterior stabilizing and cruciate retaining knee arthroplasty implants for knee replacement surgeries. These options offer customized solutions designed to meet the varying needs of patients undergoing joint replacement procedures.

Apart from its direct contribution to improving patient outcomes with its products, Globus Medical also engages in the distribution of human cell, tissue, and cellular and tissue-based products, leveraging its extensive network to facilitate availability across its served markets.

Contact Information

Address: 2560 General Armistead Avenue
Phone: 610 930 1800